Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Sanara MedTech Inc.

Get SEC filing alerts via email and in your feed for Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

About Sanara MedTech Inc.

Sanara MedTech Inc. develops and markets innovative medical technologies for surgical, wound, and skincare applications. Its core segments include Sanara Surgical, offering products like collagen and bone grafts, and Tissue Health Plus, providing value-based wound care services. The company focuses on improving clinical outcomes, reducing healthcare costs, and expanding its product pipeline through partnerships, proprietary innovations, and comprehensive care solutions across the U.S. healthcare continuum.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Sanara MedTech Inc.

1
1
Sanara MedTech Inc. Sanara MedTech Reports 19% Revenue Growth to $27.8 Million in Q1 2026

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
Sanara MedTech Inc. Sanara MedTech Reports 19% Revenue Growth to $103.1 Million for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Sanara MedTech Inc. Sanara MedTech Reports 22% Revenue Growth but Faces $30.4 Million Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Sanara MedTech Inc. Sanara MedTech Reports 28% Revenue Growth to $25.8 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Sanara MedTech Inc. Sanara MedTech Reports $23.4M Revenue in Q1 2025, Despite Increased Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Sanara MedTech Inc. Sanara MedTech Reports 33% Revenue Growth to $86.7 Million Despite Increased Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Sanara MedTech Inc. Sanara MedTech Reports 35% Revenue Growth, Increased Debt, and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments